Skip to Main Content

The (POGO) Blog

November 16, 2016

By Neil Gordon

GAO Finds Shrinking Oversight of Capitol Complex Caretaker



The Architect of the Capitol is in the final painting phase of the Dome Restoration Project Oversight activity at the Architect of the Capitol Office of Inspector General has plummeted in recent years, putting the billions of taxpayer dollars spent to maintain Capitol Hill buildings and grounds at increased risk of waste and fraud.

Continue Reading GAO Finds Shrinking Oversight of Capitol Complex Caretaker

Topics: Government Accountability, Whistleblower Protections

September 9, 2016

By Nicholas Pacifico

Independence of Inspectors General is Essential



Two businessmen POGO discusses the Partnership for Public Service’s “Walking the Line” report and highlights the importance of Inspector General independence.

Continue Reading Independence of Inspectors General is Essential

Topics: Government Accountability

May 17, 2016

By Lydia Dennett

Senate Raises Concerns Over Energy Watchdog Nominee’s Independence



Screen capture from IG nomination of Senator Ron Wyden Last week, the Senate Committee on Energy and Natural Resources held a hearing to review Susan Beard, the current nominee for the Department of Energy Inspector General position. Several Senators, including Chairwoman Murkowski and Senator Wyden, questione

Continue Reading Senate Raises Concerns Over Energy Watchdog Nominee’s Independence

Topics: Government Accountability, Energy and Natural Resources

March 23, 2016

By Elizabeth "Liz" Hempowicz

Some Issues POGO Highlighted with OSC Fixed in House Bill



Office of Special Counsel Issues POGO raised in a 2008 report about the Office of Special Counsel were addressed in a recent House Bill.

Continue Reading Some Issues POGO Highlighted with OSC Fixed in House Bill

Topics: Open Government, Whistleblower Protections

October 20, 2015

By David S. Hilzenrath

FDA Approves Antidote for Pradaxa, Calls It “Necessary”



Blood Sample Scientist Lab Five years after approving the blood thinner Pradaxa without an antidote, the FDA approved an antidote and said it was “medically necessary” when bleeding “can’t be controlled."

Continue Reading FDA Approves Antidote for Pradaxa, Calls It “Necessary”

Topics: Public Health and Science

Items 1 - 5 of 32  1234567Next

Browse POGOBlog by Topic

POGO on Facebook